Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
29 April 2022
Financial statements and reports

2021 Universal Registration Document Open in new window

20 April 2022
General meetings

Preliminary notice of the 2022 General Meeting Open in new window

25 February 2022
Corporate presentations

Corporate presentation, February 2022 Open in new window

20 January 2022
Corporate presentations

Corporate presentation, January 2022 Open in new window

06 October 2021
Corporate presentations

Corporate presentation, October 2021 Open in new window

29 July 2021
Financial statements and reports

2021 Half-Year Financial Report Open in new window

30 April 2021
General meetings

Compensation Policies Open in new window

30 April 2021
General meetings

Results of the Votes of the 2021 General Meeting Open in new window

15 April 2021
General meetings

Convening Notice – 2021 General Meeting Open in new window

08 April 2021
Financial statements and reports, General meetings

Auditors’ report on 2020 Consolidated Financial Statements in accordance with IFRS Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 14
  • View next 9 articles
© 2023 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page